-
1
-
-
0023838532
-
1antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
-
1antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501; 1990.
-
(1990)
Cell
, vol.52
, pp. 487-501
-
-
Abraham, C.R.1
Selkoe, D.J.2
Potter, H.3
-
2
-
-
0026454599
-
Thrombin accumulation in brains of patients with Alzheimer's disease
-
2. Akiyama, H.; Ikeda, K.; Kondo, H.; McGeer, P. L. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146:152-154; 1992.
-
(1992)
Neurosci. Lett.
, vol.146
, pp. 152-154
-
-
Akiyama, H.1
Ikeda, K.2
Kondo, H.3
McGeer, P.L.4
-
3
-
-
0027078106
-
Humoral and cellular immunologic repertoire in Alzheimer's disease
-
3. Amaducci, L.; Falcini, M.; Lippi, A. Humoral and cellular immunologic repertoire in Alzheimer's disease. Ann. NY Acad. Sci. 567:349-356; 1992.
-
(1992)
Ann. NY Acad. Sci.
, vol.567
, pp. 349-356
-
-
Amaducci, L.1
Falcini, M.2
Lippi, A.3
-
4
-
-
0028289083
-
Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study
-
4. Breitner, J. C. S.; Gau, B. A.; Welsh, K. A.; Plassman, B. L.; McDonald, W. M.; Helms, M. J.; Anthony, J. C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232; 1994.
-
(1994)
Neurology
, vol.44
, pp. 227-232
-
-
Breitner, J.C.S.1
Gau, B.A.2
Welsh, K.A.3
Plassman, B.L.4
McDonald, W.M.5
Helms, M.J.6
Anthony, J.C.7
-
5
-
-
0022966845
-
Evidence for the binding of human serum amyloid P component to C1q and Fab
-
5. Bristow, C. L.; Boackle, R. J. Evidence for the binding of human serum amyloid P component to C1q and Fab. Mol. Immunol. 23:1045-1052; 1986.
-
(1986)
Mol. Immunol.
, vol.23
, pp. 1045-1052
-
-
Bristow, C.L.1
Boackle, R.J.2
-
6
-
-
0028928520
-
Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain
-
6. Brugg, B.; Dubreuil, Y. L.; Huber, G.; Wollman, E. E.; Delhaye-Bouchaud, N.; Mariani, J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA 92(7):3032-3035; 1995.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, Issue.7
, pp. 3032-3035
-
-
Brugg, B.1
Dubreuil, Y.L.2
Huber, G.3
Wollman, E.E.4
Delhaye-Bouchaud, N.5
Mariani, J.6
-
7
-
-
0023953464
-
Biology of disease. Human amyloidosis, Alzheimer disease and related disorders
-
7. Castano, E. M.; Frangione, B. Biology of disease. Human amyloidosis, Alzheimer disease and related disorders. Lab. Invest. 58:122-132; 1988.
-
(1988)
Lab. Invest.
, vol.58
, pp. 122-132
-
-
Castano, E.M.1
Frangione, B.2
-
8
-
-
0025500410
-
Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases
-
8. Choi, B. H.; Suzuki, M.; Taisseung, K.; Wagner, S. L.; Cunningham, D. D. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am. J. Pathol. 137:741-747; 1990.
-
(1990)
Am. J. Pathol.
, vol.137
, pp. 741-747
-
-
Choi, B.H.1
Suzuki, M.2
Taisseung, K.3
Wagner, S.L.4
Cunningham, D.D.5
-
9
-
-
0029089023
-
Decreases in protease nexins in Alzheimer's disease brain
-
9. Choi, B. H.; Kim, R. C.; Vaughan, P. J.; Lau, A.; Van Nostrand, W.; Cunningham, D. D. Decreases in protease nexins in Alzheimer's disease brain. Neurobiol. Aging 16:557-562; 1995.
-
(1995)
Neurobiol. Aging
, vol.16
, pp. 557-562
-
-
Choi, B.H.1
Kim, R.C.2
Vaughan, P.J.3
Lau, A.4
Van Nostrand, W.5
Cunningham, D.D.6
-
11
-
-
0026476657
-
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view
-
11. Cserr, H. F.; Knopf, P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:507-512; 1992.
-
(1992)
Immunol Today
, vol.13
, pp. 507-512
-
-
Cserr, H.F.1
Knopf, P.M.2
-
12
-
-
0022830824
-
Complement in the pathophysiology and diagnosis of human diseases
-
12. Dalmasso, A. P. Complement in the pathophysiology and diagnosis of human diseases. CRC Crit. Rev. Clin. Lab. Sci. 24:123-183; 1986.
-
(1986)
CRC Crit. Rev. Clin. Lab. Sci.
, vol.24
, pp. 123-183
-
-
Dalmasso, A.P.1
-
13
-
-
0028889206
-
Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1
-
13. Das, S.; Potter, H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14:447-456; 1995.
-
(1995)
Neuron
, vol.14
, pp. 447-456
-
-
Das, S.1
Potter, H.2
-
14
-
-
0028937265
-
Enhanced processing of APP induced by IL-1β can be reduced by indomethacin and nordihdroguaiaretic acid
-
14. Dash, P. K.; Moore, A. N. Enhanced processing of APP induced by IL-1β can be reduced by indomethacin and nordihdroguaiaretic acid. Biochem. Biophys. Res. Commun. 208:542-548; 1995.
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.208
, pp. 542-548
-
-
Dash, P.K.1
Moore, A.N.2
-
15
-
-
0028946146
-
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
-
15. Del Bo, R.; Angeretti, N.; Lucca, E.; De Simoni, M. G.; Forloni, G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci. Lett, 188:70-74; 1995.
-
(1995)
Neurosci. Lett
, vol.188
, pp. 70-74
-
-
Del Bo, R.1
Angeretti, N.2
Lucca, E.3
De Simoni, M.G.4
Forloni, G.5
-
16
-
-
0023727951
-
Schwäble structural and functional relationships among receptors and regulators of the complement system
-
16. Dierich, M. P.; Schulz, T. F.; Eigentler, A.; Huemer, H.; Schwäble Structural and functional relationships among receptors and regulators of the complement system. Mol. Immunol. 25:1043-1051; 1988.
-
(1988)
Mol. Immunol.
, vol.25
, pp. 1043-1051
-
-
Dierich, M.P.1
Schulz, T.F.2
Eigentler, A.3
Huemer, H.4
-
17
-
-
0025610195
-
Interleukin-1 stimulates the beta-amyloid precursor protein promoter
-
17. Donnelly, R. J.; Friedhoff, A. J.; Beer, B.; Blume, A. J.; Vitek, M. P. Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell. Mol. Neurobiol. 10:485-492; 1990.
-
(1990)
Cell. Mol. Neurobiol.
, vol.10
, pp. 485-492
-
-
Donnelly, R.J.1
Friedhoff, A.J.2
Beer, B.3
Blume, A.J.4
Vitek, M.P.5
-
18
-
-
0028061449
-
Towards a pharmacological approach of Alzheimer's disease based on the molecular biology of the amyloid precursor protein (APP)
-
18. Dresse, A.; Marechal, D.; Scuvee-Moreau, J.; Seutin, V. Towards a pharmacological approach of Alzheimer's disease based on the molecular biology of the amyloid precursor protein (APP). Life Sci. 55: 2179-2187; 1994.
-
(1994)
Life Sci.
, vol.55
, pp. 2179-2187
-
-
Dresse, A.1
Marechal, D.2
Scuvee-Moreau, J.3
Seutin, V.4
-
19
-
-
0024340461
-
Immunodetection of the amyloid P component in Alzheimer's disease
-
19. Duong, T.; Pommier, E. C.; Scheibel, A. B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. 78: 429-437; 1989.
-
(1989)
Acta Neuropathol.
, vol.78
, pp. 429-437
-
-
Duong, T.1
Pommier, E.C.2
Scheibel, A.B.3
-
20
-
-
0028099622
-
Inflammatory mechanisms in Alzheimer's disease
-
20. Eikelenboom, P.; Zhan, S. S.; van Gool, W. A.; Allsop, D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15: 447-450; 1994.
-
(1994)
Trends Pharmacol. Sci.
, vol.15
, pp. 447-450
-
-
Eikelenboom, P.1
Zhan, S.S.2
Van Gool, W.A.3
Allsop, D.4
-
21
-
-
0028144369
-
Structure of pentameric human serum amyloid P component
-
21. Emsley, J.; White H. E.; O'Hara, B. P.; Oliva, G.; Srinivasan, N.; Tickle, I. J.; Blundell, T. L.; Pepys, M. B., Wood, S. P. Structure of pentameric human serum amyloid P component. Nature 367:338-345; 1994.
-
(1994)
Nature
, vol.367
, pp. 338-345
-
-
Emsley, J.1
White, H.E.2
O'Hara, B.P.3
Oliva, G.4
Srinivasan, N.5
Tickle, I.J.6
Blundell, T.L.7
Pepys, M.B.8
Wood, S.P.9
-
22
-
-
0025781819
-
The role of complement in inflammation and phagocytosis
-
22. Frank, M. M.; Fries, L. F. The role of complement in inflammation and phagocytosis. Immunol. Today 12:322-326; 1991.
-
(1991)
Immunol. Today
, vol.12
, pp. 322-326
-
-
Frank, M.M.1
Fries, L.F.2
-
23
-
-
0027363674
-
Expression of the complement classical pathway by human glioma in culture
-
23. Gasque, P.; Ischenko, A.; Legoedec, J.; Mauger, C.; Schouft, M.-T.; Fontaine, M. Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem, 268:25068-25074; 1993.
-
(1993)
J. Biol. Chem
, vol.268
, pp. 25068-25074
-
-
Gasque, P.1
Ischenko, A.2
Legoedec, J.3
Mauger, C.4
Schouft, M.-T.5
Fontaine, M.6
-
24
-
-
0029053689
-
Complement expression in human brain: Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines
-
24. Gasque, P.; Fontaine, M.; Morgan, B. P. Complement expression in human brain: Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154:4726-4733; 1995.
-
(1995)
J. Immunol.
, vol.154
, pp. 4726-4733
-
-
Gasque, P.1
Fontaine, M.2
Morgan, B.P.3
-
25
-
-
0023847698
-
Acute-phase proteins in Alzheimer's disease
-
25. Giometto, B.; Argentiero, V.; Sanson, F.; Ongaro, G.; Tavolato, B. Acute-phase proteins in Alzheimer's disease. Eur. Neurol. 28:30-33; 1988.
-
(1988)
Eur. Neurol.
, vol.28
, pp. 30-33
-
-
Giometto, B.1
Argentiero, V.2
Sanson, F.3
Ongaro, G.4
Tavolato, B.5
-
26
-
-
0005775566
-
Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells
-
26. Goldgaber, D.; Harris, H. W.; Hla, T.; Maciag, T.; Donelly, R. J.; Jacobson, J. S.; Vitek, M. P.; Gajdusek, D. C. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86:7606-7610; 1989.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 7606-7610
-
-
Goldgaber, D.1
Harris, H.W.2
Hla, T.3
Maciag, T.4
Donelly, R.J.5
Jacobson, J.S.6
Vitek, M.P.7
Gajdusek, D.C.8
-
28
-
-
0026543138
-
Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation
-
28. Gordon, D. L.; Sadlon, T. A.; Wesselingh, S. L.; Russell, S. M.; Johnstone, R. W.; Purcell, D. F. J. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J. Neuroimmunol. 36:199-208; 1992.
-
(1992)
J. Neuroimmunol.
, vol.36
, pp. 199-208
-
-
Gordon, D.L.1
Sadlon, T.A.2
Wesselingh, S.L.3
Russell, S.M.4
Johnstone, R.W.5
Purcell, D.F.J.6
-
29
-
-
0027468515
-
Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells
-
29. Haga, S.; Ikeda, K.; Sato, M.; Ishii, T. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601:88-94; 1993.
-
(1993)
Brain Res.
, vol.601
, pp. 88-94
-
-
Haga, S.1
Ikeda, K.2
Sato, M.3
Ishii, T.4
-
30
-
-
0028217539
-
Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease
-
30. Itagaki, S.; Akiyama, H.; Saito, H.; McGeer, P. L. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Res. 645:78-84; 1994.
-
(1994)
Brain Res.
, vol.645
, pp. 78-84
-
-
Itagaki, S.1
Akiyama, H.2
Saito, H.3
McGeer, P.L.4
-
31
-
-
0027938567
-
Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections
-
31. Iwamoto, N.; Nishiyama, E.; Ohwada, J.; Arai, H. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci. Lett. 177:23-26; 1994.
-
(1994)
Neurosci. Lett.
, vol.177
, pp. 23-26
-
-
Iwamoto, N.1
Nishiyama, E.2
Ohwada, J.3
Arai, H.4
-
32
-
-
0028178458
-
β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain
-
32. Jiang, H.; Burdick, D.; Glabe, C. G.; Cotman, C. W.; Tenner, A. J. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain, J. Immunol., 152:5050-5059; 1994.
-
(1994)
J. Immunol.
, vol.152
, pp. 5050-5059
-
-
Jiang, H.1
Burdick, D.2
Glabe, C.G.3
Cotman, C.W.4
Tenner, A.J.5
-
33
-
-
0026622098
-
Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning
-
33. Johnson, S. A.; Lampert-Etchells, M.; Pasinetti, G. M.; Rozovsky, I.; Finch, C. E. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging 13:641-648; 1992.
-
(1992)
Neurobiol. Aging
, vol.13
, pp. 641-648
-
-
Johnson, S.A.1
Lampert-Etchells, M.2
Pasinetti, G.M.3
Rozovsky, I.4
Finch, C.E.5
-
34
-
-
0026662246
-
Serum amyloid P and related molecules associated with the acute phase response in Alzheimer's disease
-
34. Kalaria, R. N. Serum amyloid P and related molecules associated with the acute phase response in Alzheimer's disease. Res. Immunol. 143: 637-641; 1992.
-
(1992)
Res. Immunol.
, vol.143
, pp. 637-641
-
-
Kalaria, R.N.1
-
35
-
-
0026915263
-
The blood-brain barrier and cerebral microcirculation in Alzheimer's disease
-
35. Kalaria, R. N. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev. 4:226-260; 1992.
-
(1992)
Cerebrovasc. Brain Metab. Rev.
, vol.4
, pp. 226-260
-
-
Kalaria, R.N.1
-
36
-
-
0027372206
-
The immunopathology of Alzheimer's disease and some related disorders
-
36. Kalaria, R. N. The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3:333-347; 1993.
-
(1993)
Brain Pathol.
, vol.3
, pp. 333-347
-
-
Kalaria, R.N.1
-
37
-
-
0025309009
-
Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: Implications for leakage across the blood-brain barrier in Alzheimer's disease
-
37. Kalaria, R. N.; Grahavac, I. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: Implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516: 349-353; 1990.
-
(1990)
Brain Res.
, vol.516
, pp. 349-353
-
-
Kalaria, R.N.1
Grahavac, I.2
-
38
-
-
0026775412
-
Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease
-
38. Kalaria, R. N.; Kroon, S. N. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem. Biophys. Res. Commun. 186:461-466; 1992.
-
(1992)
Biochem. Biophys. Res. Commun.
, vol.186
, pp. 461-466
-
-
Kalaria, R.N.1
Kroon, S.N.2
-
39
-
-
0027493189
-
Amyloid P component and other acute phase proteins in cerebellar Aβ deposits of Alzheimer's disease
-
39. Kalaria, R. N.; Perry, G. Amyloid P component and other acute phase proteins in cerebellar Aβ deposits of Alzheimer's disease. Brain Res. 631:151-155; 1993.
-
(1993)
Brain Res.
, vol.631
, pp. 151-155
-
-
Kalaria, R.N.1
Perry, G.2
-
40
-
-
0025905126
-
Widespread amyloid P component immunoreactivity in cortical amyloid deposits of Alzheimer's disease and other degenerative disorders
-
40. Kalaria, R. N.; Galloway, P. G.; Perry, G. Widespread amyloid P component immunoreactivity in cortical amyloid deposits of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17:189-201; 1991.
-
(1991)
Neuropathol. Appl. Neurobiol.
, vol.17
, pp. 189-201
-
-
Kalaria, R.N.1
Galloway, P.G.2
Perry, G.3
-
41
-
-
0000268244
-
Absence of detectable mRNA for serum amyloid P (SAP) in human brain, choroid plexus, and meninges suggests that the presence of SAP in CSF is due to transport across the blood-brain barrier
-
41. Kalaria, R. N.; Golde, T; Cohen, M. L.; Younkin, L. H.; Younkin, S. Absence of detectable mRNA for serum amyloid P (SAP) in human brain, choroid plexus, and meninges suggests that the presence of SAP in CSF is due to transport across the blood-brain barrier. J. Neuropathol. Exp. Neurol. 50:339; 1991.
-
(1991)
J. Neuropathol. Exp. Neurol.
, vol.50
, pp. 339
-
-
Kalaria, R.N.1
Golde, T.2
Cohen, M.L.3
Younkin, L.H.4
Younkin, S.5
-
42
-
-
0027731226
-
The serine protease inhibitor antithrombin III and its mRNA in the pathogenesis of Alzheimer's disease
-
42. Kalaria, R. N.; Golde, T. E.; Kroon, S. N.; Perry, G. The serine protease inhibitor antithrombin III and its mRNA in the pathogenesis of Alzheimer's disease. Am. J. Pathol. 143:1-8; 1993.
-
(1993)
Am. J. Pathol.
, vol.143
, pp. 1-8
-
-
Kalaria, R.N.1
Golde, T.E.2
Kroon, S.N.3
Perry, G.4
-
44
-
-
0028916902
-
Design, synthesis and evaluation of A/C/D-Ring analogs of the fungal metabolite K-76 as potential complement inhibitors
-
44. Kaufman, T. S.; Srivastava, R. P.; Sindelar, R. D. Design, synthesis and evaluation of A/C/D-Ring analogs of the fungal metabolite K-76 as potential complement inhibitors. J. Med. Chem. 38:1437-1445; 1995.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 1437-1445
-
-
Kaufman, T.S.1
Srivastava, R.P.2
Sindelar, R.D.3
-
45
-
-
0001101781
-
Cell adhesion molecules in the vascular and neocortical pathology of Alzheimer's disease
-
45. Lerner, A.; Cohen, D. L.; Pax, A. B.; Friedland, R.; Kalaria, R. N. Cell adhesion molecules in the vascular and neocortical pathology of Alzheimer's disease. Soc. Neurosci. Abstr. 19:623; 1993.
-
(1993)
Soc. Neurosci. Abstr.
, vol.19
, pp. 623
-
-
Lerner, A.1
Cohen, D.L.2
Pax, A.B.3
Friedland, R.4
Kalaria, R.N.5
-
46
-
-
0027104778
-
Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum
-
46. Lue, L.-F.; Rogers, J. Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum. Dementia 3:308-313; 1992.
-
(1992)
Dementia
, vol.3
, pp. 308-313
-
-
Lue, L.-F.1
Rogers, J.2
-
47
-
-
0028173205
-
1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
-
1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94; 1994.
-
(1994)
Nature
, vol.372
, pp. 92-94
-
-
Ma, J.1
Yee, A.2
Brewer, H.B.3
Das, S.4
Potter, H.5
-
48
-
-
0026739154
-
Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration
-
48. May, P. C.; Finch, C. E. Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 15(10):391-395; 1991.
-
(1991)
Trends Neurosci.
, vol.15
, Issue.10
, pp. 391-395
-
-
May, P.C.1
Finch, C.E.2
-
49
-
-
0026551329
-
Medical hypothesis: Anti-inflammatory agents as a therapeutic approach to Alzheimer disease
-
49. McGeer, P. L.; Rogers, J. Medical hypothesis: anti-inflammatory agents as a therapeutic approach to Alzheimer disease. Neurology 42:447-449; 1992.
-
(1992)
Neurology
, vol.42
, pp. 447-449
-
-
McGeer, P.L.1
Rogers, J.2
-
50
-
-
0024442083
-
Immune system response in Alzheimer disease
-
50. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Immune system response in Alzheimer disease. Can. J. Neurol. Sci. 16:516-527; 1989.
-
(1989)
Can. J. Neurol. Sci.
, vol.16
, pp. 516-527
-
-
McGeer, P.L.1
Akiyama, H.2
Itagaki, S.3
McGeer, E.G.4
-
51
-
-
0026699919
-
Immune responses in brain of Alzheimer's and Parkinson's disease patients: Hypothesis and reality
-
51. McRae, A.; Dahlstrom, A. Immune responses in brain of Alzheimer's and Parkinson's disease patients: Hypothesis and reality. Rev. Neurosci. 3:79-97; 1992.
-
(1992)
Rev. Neurosci.
, vol.3
, pp. 79-97
-
-
McRae, A.1
Dahlstrom, A.2
-
52
-
-
0028953529
-
Activation of microglial cells by β-amyloid and interferon-gamma
-
52. Meda, L.; Cassatella, M. A.; Szendrei, G. I.; Otvos, L.; Baron, P.; Villalba, M.; Ferrari, D.; Rossi, F. Activation of microglial cells by β-amyloid and interferon-gamma. Nature 374:647-650; 1995.
-
(1995)
Nature
, vol.374
, pp. 647-650
-
-
Meda, L.1
Cassatella, M.A.2
Szendrei, G.I.3
Otvos, L.4
Baron, P.5
Villalba, M.6
Ferrari, D.7
Rossi, F.8
-
53
-
-
0003056313
-
Complement and β-amyloid (Aβ) neurotoxicity in vitro: A model for Alzheimer's disease
-
53. Oda, T.; Lehrer-Graiwer, J.; Finch, C. E.; Pasinetti, G. M. Complement and β-amyloid (Aβ) neurotoxicity in vitro: A model for Alzheimer's disease. Alzheimer Res. 1:29-34; 1995.
-
(1995)
Alzheimer Res.
, vol.1
, pp. 29-34
-
-
Oda, T.1
Lehrer-Graiwer, J.2
Finch, C.E.3
Pasinetti, G.M.4
-
54
-
-
0025084275
-
Antibodies to viral anigens, xenoantigens and autoantigens in Alzheimer's disease
-
54. Ounanian, A.; Guilbert, B.; Renversez, J.-C.; Seigneurin, J.-M.; Avrameas, S. Antibodies to viral anigens, xenoantigens and autoantigens in Alzheimer's disease. J. Clin. Lab. Anal. 4:367-375; 1990.
-
(1990)
J. Clin. Lab. Anal.
, vol.4
, pp. 367-375
-
-
Ounanian, A.1
Guilbert, B.2
Renversez, J.-C.3
Seigneurin, J.-M.4
Avrameas, S.5
-
56
-
-
0023927787
-
Amyloidosis: Some recent developments
-
56. Pepys, M. B. Amyloidosis: Some recent developments. Q. J. Med. 67:283-298; 1988.
-
(1988)
Q. J. Med.
, vol.67
, pp. 283-298
-
-
Pepys, M.B.1
-
57
-
-
0025100927
-
Distribution of the protease inhibitor α-1-antichymotrypsin in cerebral and system amyloid
-
57. Picken, M. M.; Larrondo-Lillo, M.; Coria, F.; Gallo, G. R.; Shelanski, M. L.; Frangione, B. Distribution of the protease inhibitor α-1-antichymotrypsin in cerebral and system amyloid. J. Neuropathol. Exp. Neurol. 49:41-48; 1990.
-
(1990)
J. Neuropathol. Exp. Neurol.
, vol.49
, pp. 41-48
-
-
Picken, M.M.1
Larrondo-Lillo, M.2
Coria, F.3
Gallo, G.R.4
Shelanski, M.L.5
Frangione, B.6
-
58
-
-
0023953413
-
Hemostatic properties of normal and perturbed vascular cells
-
58. Rodgers, G. M. Hemostatic properties of normal and perturbed vascular cells. FASEB J. 2:116-123; 1988.
-
(1988)
FASEB J.
, vol.2
, pp. 116-123
-
-
Rodgers, G.M.1
-
59
-
-
0029101491
-
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
-
59. Rogaev, E. I.; Sherrington, R.; Rogaeva, E. A.; et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778; 1995.
-
(1995)
Nature
, vol.376
, pp. 775-778
-
-
Rogaev, E.I.1
Sherrington, R.2
Rogaeva, E.A.3
-
60
-
-
0026447529
-
Complement activation by β-amyloid in Alzheimer disease
-
60. Rogers, J.; Cooper, N. R.; Webster, S.; Schultz, J.; McGeer, P. L.; Styren, S. D.; Civin, W. H.; Brachova, L.; Bradt, B.; Ward, P.; Lieberburg, I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89:10016-10020; 1992.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 10016-10020
-
-
Rogers, J.1
Cooper, N.R.2
Webster, S.3
Schultz, J.4
McGeer, P.L.5
Styren, S.D.6
Civin, W.H.7
Brachova, L.8
Bradt, B.9
Ward, P.10
Lieberburg, I.11
-
61
-
-
0027268393
-
Clinical trial of indomethacin in Alzheimer's disease
-
61. Rogers, J.; Kirby, L. C.; Hempelman, S. R.; Berry, D. L.; McGeer, P. L.; Kaszniak, A. W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Wilson, P. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611; 1993.
-
(1993)
Neurology
, vol.43
, pp. 1609-1611
-
-
Rogers, J.1
Kirby, L.C.2
Hempelman, S.R.3
Berry, D.L.4
McGeer, P.L.5
Kaszniak, A.W.6
Zalinski, J.7
Cofield, M.8
Mansukhani, L.9
Wilson, P.10
-
62
-
-
0027936838
-
Apolipoprotein E affects the rate of Alzheimer disease expression: β-Amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease
-
62. Roses, A. D. Apolipoprotein E affects the rate of Alzheimer disease expression: β-Amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease, J. Neuropathol. Exp. Neurol. 53:429-437; 1994.
-
(1994)
J. Neuropathol. Exp. Neurol.
, vol.53
, pp. 429-437
-
-
Roses, A.D.1
-
63
-
-
0024428072
-
A4 protein in Alzheimer's disease; Primary and secondary cellular events in extracellular amyloid deposition
-
63. Rozemuller, J. M.; Eikelenboom, P.; Stam, F. C.; Beyreuther, K.; Masters, C. L. A4 protein in Alzheimer's disease; Primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48:647-663; 1989.
-
(1989)
J. Neuropathol. Exp. Neurol.
, vol.48
, pp. 647-663
-
-
Rozemuller, J.M.1
Eikelenboom, P.2
Stam, F.C.3
Beyreuther, K.4
Masters, C.L.5
-
64
-
-
0025774120
-
1antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. An immunohistochemical study with monoclonal antibodies against native and inactivated α-antichymotrypsin
-
1antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. An immunohistochemical study with monoclonal antibodies against native and inactivated α-antichymotrypsin. Acta Neuropathol. 82:200-207; 1991.
-
(1991)
Acta Neuropathol.
, vol.82
, pp. 200-207
-
-
Rozemuller, J.M.1
Abbink, J.J.2
Kamp, A.M.3
Stam, F.C.4
Hack, C.E.5
Eikelenboom, P.6
-
65
-
-
0028932861
-
Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system
-
65. Schlimgen, A. K.; Helms, J. A.; Vogel, H.; Perin, M. S. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system. Neuron 14:519-526; 1995.
-
(1995)
Neuron
, vol.14
, pp. 519-526
-
-
Schlimgen, A.K.1
Helms, J.A.2
Vogel, H.3
Perin, M.S.4
-
66
-
-
0028267440
-
Normal and abnormal biology of the β-amyloid precursor protein
-
66. Selkoe, D. J. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:489-517; 1994.
-
(1994)
Annu. Rev. Neurosci.
, vol.17
, pp. 489-517
-
-
Selkoe, D.J.1
-
67
-
-
0026646605
-
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
-
67. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindelhurst, C.; mcCormack, R.; Wolfert, R.; Selkoe, D.; Liebeurberg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
-
Nature
, vol.359
, pp. 325-327
-
-
Seubert, P.1
Vigo-Pelfrey, C.2
Esch, F.3
Lee, M.4
Dovey, H.5
Davis, D.6
Sinha, S.7
Schlossmacher, M.8
Whaley, J.9
Swindelhurst, C.10
McCormack, R.11
Wolfert, R.12
Selkoe, D.13
Liebeurberg, I.14
Schenk, D.15
-
69
-
-
0028181396
-
Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid
-
69. Tabaton, M.; Nunzi, M. G.; Xue, R.; Usiak, M.; Autilio-Gambetti, L.; Gambetti, P. Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem. Biophys. Res. Commun. 200:1598-1603; 1994.
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.200
, pp. 1598-1603
-
-
Tabaton, M.1
Nunzi, M.G.2
Xue, R.3
Usiak, M.4
Autilio-Gambetti, L.5
Gambetti, P.6
-
70
-
-
0029010736
-
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis
-
70. Tennent, G.; Lovat, L. B.; Pepys, M. B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA 92:4299-4303; 1995.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 4299-4303
-
-
Tennent, G.1
Lovat, L.B.2
Pepys, M.B.3
-
71
-
-
0029089479
-
Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3
-
71. Veerhuis, R.; van der Vaik, P.; Janssen, I.; Zhan, S. S.; Van Nostrand, W. E.; Eikelenboom, P. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3. Virchows Arch. 426:603-610; 1995.
-
(1995)
Virchows Arch.
, vol.426
, pp. 603-610
-
-
Veerhuis, R.1
Van Der Vaik, P.2
Janssen, I.3
Zhan, S.S.4
Van Nostrand, W.E.5
Eikelenboom, P.6
-
72
-
-
0024853588
-
Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease
-
72. Wagner, S. L.; Geddes, J. W.; Cotman, C. W.; Lau, A.L.; Gurwitz, D.; Isackson, P. J.; Cunningham, D. D. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:8284-8288; 1989.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 8284-8288
-
-
Wagner, S.L.1
Geddes, J.W.2
Cotman, C.W.3
Lau, A.L.4
Gurwitz, D.5
Isackson, P.J.6
Cunningham, D.D.7
-
73
-
-
0025354456
-
Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis
-
73. Weisman, H. F.; Bartow, T.; Leppo, M. K.; Marsh, H. C.; Carson, G. R.; Concino, M. F.; Boyle, M. P.; Roux, K. H.; Weisfeldt M. L.; Fearon, D. T. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science 249:146-151; 1990.
-
(1990)
Science
, vol.249
, pp. 146-151
-
-
Weisman, H.F.1
Bartow, T.2
Leppo, M.K.3
Marsh, H.C.4
Carson, G.R.5
Concino, M.F.6
Boyle, M.P.7
Roux, K.H.8
Weisfeldt, M.L.9
Fearon, D.T.10
-
75
-
-
0027453380
-
Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1β or IL-IRA but increases in the associated acute phase proteins IL-6, a2-macroglobulin and C-reactive protein
-
75. Wood, J. A.; Wood, P. L.; Ryan R.; Graff-Radford, N. R.; Pilapil, C.; Robitaille, Y.; Quirion, R. Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1β or IL-IRA but increases in the associated acute phase proteins IL-6, a2-macroglobulin and C-reactive protein. Brain Res. 629:245-252; 1993.
-
(1993)
Brain Res.
, vol.629
, pp. 245-252
-
-
Wood, J.A.1
Wood, P.L.2
Ryan, R.3
Graff-Radford, N.R.4
Pilapil, C.5
Robitaille, Y.6
Quirion, R.7
-
76
-
-
0027394985
-
Human serum amyloid P component oligomers bind and activate the classical complement-pathway via residues 14-26 and 76-92 of the Achain collagen-like region of C1q
-
76. Ying, S.-C.; Gewurz, A. T.; Jiang, H.; Gewurz, H. Human serum amyloid P component oligomers bind and activate the classical complement-pathway via residues 14-26 and 76-92 of the Achain collagen-like region of C1q. J. Immunol. 150:169-176; 1993.
-
(1993)
J. Immunol.
, vol.150
, pp. 169-176
-
-
Ying, S.-C.1
Gewurz, A.T.2
Jiang, H.3
Gewurz, H.4
|